What are you looking for?
Search
Cagri + Semaglutide (1 Box) - 99% Purity Research Peptide
✅ Sold as 1 Full Box (10 Vials) Each vial = 5/10mg | Research Use Only
(18)Cagri + Semaglutide - Dual-pathway research combination targeting amylin and GLP-1 receptors. Studied in appetite regulation, metabolic function, glucose metabolism, and body-weight research. Combines two complementary mechanisms in one research formulation.
Dual-pathway combination (Cagrilintide + Semaglutide)
Targets amylin and GLP-1 receptor pathways for metabolic and appetite-regulation research
Research-grade combination
✅ HPLC Purity Analysis
Confirms the peptide is ≥99% pure
✅ Mass Spectrometry
Verifies the exact molecular identity
✅ Heavy Metals Screening
Lead, arsenic, cadmium & mercury - Pass
✅ Endotoxins (LPS)
Bacterial endotoxin levels - Pass
✅ Sterility Testing
No microbial contamination - Pass
✅ TFA Content
Residual trifluoroacetic acid - Not Detected
✅ Net Peptide Content
Actual peptide mass per vial verified
✅ HPLC Purity Analysis
Confirms the peptide is ≥99% pure
✅ Mass Spectrometry
Verifies the exact molecular identity
✅ Heavy Metals Screening
Lead, arsenic, cadmium & mercury - Pass
✅ Endotoxins (LPS)
Bacterial endotoxin levels - Pass
✅ Sterility Testing
No microbial contamination - Pass
✅ TFA Content
Residual trifluoroacetic acid - Not Detected
✅ Net Peptide Content
Actual peptide mass per vial verified
Description
Cagri + Semaglutide is a combination research compound featuring cagrilintide and semaglutide. Cagrilintide is an amylin analogue, while semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. Both compounds have been characterized in research involving appetite regulation, energy balance, metabolic signaling, and incretin-related pathways. Nova supplies Cagri + Semaglutide in a lyophilized vial that requires reconstitution with a suitable solvent before research use. Every batch is triple-tested by an independent, ISO/IEC 17025-accredited laboratory. For research use only. Not for human or animal consumption.